These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28705709)

  • 1. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
    Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
    Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
    Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
    Kilpatrick SE
    Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
    Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
    Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
    Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
    Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double minute chromosomes harboring MDM2 amplification in a pediatric atypical lipomatous tumor.
    Dadone-Montaudié B; Burel-Vandenbos F; Soler C; Rosello O; Boyer C; Fabas T; Bianchini L; Pedeutour F
    Genes Chromosomes Cancer; 2019 Sep; 58(9):673-679. PubMed ID: 30887579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
    Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
    Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient.
    Kukull BJ; Khalighi MA; Gundle KR; Hansford BG; Corless CL; Davis JL
    Pediatr Dev Pathol; 2020; 23(3):240-246. PubMed ID: 31739757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
    Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
    Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
    Thway K
    Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
    Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
    Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
    Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
    Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
    Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis.
    Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T
    Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
    Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
    Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-differentiated spindle cell liposarcoma ('atypical spindle cell lipomatous tumor') does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases.
    Mentzel T; Palmedo G; Kuhnen C
    Mod Pathol; 2010 May; 23(5):729-36. PubMed ID: 20228779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.